NON-NEUTRALIZING ANTIBODIES ELICITED BY RECOMBINANT LASSA-RABIES VACCINE ARE CRITICAL FOR PROTECTION AGAINST LASSA FEVER
Technology
E-148-2019
Patent ID
E-148-2019-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
62/691,413
IC
NIAID
Date Filed
Date Issued
Patent PDF